Renal Cell Carcinoma (RCC) 

For patients with localized renal cell carcinoma, when comprehensive imaging evaluation confirms that the tumor size, location, and surgical complexity are technically feasible, robot-assisted nephron-sparing surgery is considered the preferred surgical approach. This technique achieves complete tumor excision while preserving maximal normal renal parenchyma, thereby maintaining long-term renal function. Compared with traditional open surgery or conventional laparoscopic approaches, robotic systems provide high-definition three-dimensional visualization and enhanced instrument dexterity, enabling more precise tumor resection and renal reconstruction. These advantages contribute to reduced blood loss, shorter renal ischemia time, and a lower risk of postoperative complications, as well as decreased postoperative pain, faster recovery, and shorter hospital stays, making it an important contemporary strategy in the surgical management of renal cell carcinoma.

• High surgical volume: nationally leading
• Low major complication rate: world-class level
• Highest tumor complexity with 100% negative surgical margins: world-leading
• Five-year survival approaching 100%: world-class level
• Retroperitoneal tumor resection, ideal for patients with intra-abdominal adhesions or obesity
• High nephron preservation, minimal long-term impact on renal function
• Innovation: Use of local Taiwanese population data to predict patients at high risk for postoperative bleeding